Evidence map›Paper›PMID 41228303›Full record

ArticleCancers2025

Authors' Protocol of Central Giant Cell Granuloma Effective Treatment in the Jawbone.

Dominik Szczeciński, Patrycja Ujma, Katarzyna Radwańska, Piotr Szymor, Marcin Kozakiewicz

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dominik SzczecińskiDepartment of Maxillofacial Surgery, Medical University of Lodz, 92-213 Lodz, Poland.
Patrycja UjmaDepartment of Maxillofacial Surgery, Medical University of Lodz, 92-213 Lodz, Poland.
Katarzyna RadwańskaDepartment of Maxillofacial Surgery, Medical University of Lodz, 92-213 Lodz, Poland.
Piotr SzymorDepartment of Maxillofacial Surgery, Medical University of Lodz, 92-213 Lodz, Poland.ORCID 0000-0002-6768-5812
Marcin KozakiewiczDepartment of Maxillofacial Surgery, Medical University of Lodz, 92-213 Lodz, Poland.ORCID 0000-0001-9200-2828

Funding

Medical University of Lodz 503/1-138-01/503-11/001
6 · The paper itself

Abstract

backgroundCentral giant cell granuloma of the jaw is a benign but potentially aggressive lesion that can cause pain, facial deformity, tooth loss, and jaw destruction. Many treatment methods are described in the literature, but the less invasive ones are associated with a higher recurrence rate. For several decades, extensive bone resection procedures have been the most effective treatment to date. This study aimed to evaluate a minimally invasive treatment protocol combining multiple weekly intralesional steroid injections with surgical removal of residual tumor tissue and chemical cauterization using Carnoy's solution.

methodsThirteen patients with histologically confirmed central giant cell granulomas of the jaws were treated according to the protocol, including weekly triamcinolone injections and, when necessary, fenestration of the cortical bone to access residual lesions. Patients were monitored clinically and radiologically over six years, with reconstruction of bone defects using autogenous grafts and platelet-rich fibrin.

resultsThe treatment effectively reduced tumor size, restored cortical bone, and allowed preservation of jaw structure. Only one recurrence was observed, and complications were minor and transient. The protocol was equally effective for both aggressive and non-aggressive lesions, regardless of patient age or comorbidities.

conclusionsThese findings suggest that combining pharmacological and surgical approaches with chemical cauterization provides a safe, effective, and tissue-preserving strategy for managing central giant cell granulomas, minimizing recurrence while reducing surgical morbidity.

Indexed as

Carnoy solutioncentral giant cell granulomaCGCGchildrenjawsradicalizationrecurrencesteroidssurgerytreatment

Identifiers

PMID41228303
PMCPMC12610363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.